Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood

Affiliations

¹ Department of Medical Biotechnologies, University of Siena, Siena, Italy, Phone: +39 0577 233910, Fax: +39 0577 233870.
² Department of Medical Biotechnologies, University of Siena, Siena, Italy.
³ Unit of Infectious Diseases, Department of Medicine, University of Perugia, Perugia, Italy.

Ilaria Vicenti et al. Clin Chem Lab Med. 2018.

. 2018 Feb 23;56(3):e75-e77.

doi: 10.1515/cclm-2017-0587.

¹ Department of Medical Biotechnologies, University of Siena, Siena, Italy, Phone: +39 0577 233910, Fax: +39 0577 233870.
² Department of Medical Biotechnologies, University of Siena, Siena, Italy.
³ Unit of Infectious Diseases, Department of Medicine, University of Perugia, Perugia, Italy.

No abstract available

Keywords: HIV-1 reservoir; HIV-1 total DNA; quantitation; real time PCR.

References

1. Massanella M, Richman DD. Measuring the latent reservoir in vivo. J Clin Invest 2016;126:464–72.
1. Kiselinova M, De Spiegelaere W, Buzon MJ, Malatinkova E, Lichterfeld M, Vandekerckhove L. Integrated and total HIV-1 DNA predict ex vivo viral outgrowth. PLoS Pathog 2016;12:e1005472.
1. Tsiara CG, Nikolopoulos GK, Bagos PG, Goujard C, Katzenstein TL, Minga AK, et al. Impact of HIV type 1 DNA levels on spontaneous disease progression: a meta-analysis. AIDS Res Hum Retroviruses 2012;28:366–73.
1. Williams JP, Hurst J, Stöhr W, Robinson N, Brown H, Fisher M, et al. HIV-1 DNA predicts disease progression and post-treatment virological control. Elife 2014;3:e03821.
1. Lambert-Niclot S, Flandre P, Valantin MA, Peytavin G, Duvivier C, Haim-Boukobza S, et al. Factors associated with virological failure in HIV-1-infected patients receiving darunavir/ritonavir monotherapy. J Infect Dis 2011;204:1211–6.